This inventor holds 3 USPTO granted patents. Top assignees: Boehringer Ingelheim Kg, Orion-Yhtyma Oy. Active years: 1998-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1998-2002
Title: The Innovative Contributions of Harald Sprenger
Introduction
Harald Sprenger is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of aerosol inhalers, holding a total of 3 patents. His work has had a profound impact on therapeutic delivery systems, enhancing the efficacy of inhalation therapies.
Latest Patents
One of Harald Sprenger's latest patents involves an innovative aerosol inhaler design. This design proposes the integration of a thermal sensor positioned near the atomization nozzle. Upon the actuation of an inhalation process, the sensor experiences cooling due to the expansion of the propellant. This cooling effect is electronically detected by a module, allowing for the derivation of technical and therapeutic data. This data can then be communicated to the user through a display unit or alarm devices, ultimately influencing therapy in a desired manner.
Career Highlights
Throughout his career, Harald Sprenger has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim and Orion-yhtyma Oy. His experience in these organizations has contributed to his expertise in developing advanced inhalation technologies.
Collaborations
Harald has collaborated with several professionals in his field, including Klaus Nohl and Klaus Nöhl. These collaborations have fostered innovation and the sharing of ideas, further enhancing the development of his patented technologies.
Conclusion
Harald Sprenger's contributions to aerosol inhaler technology exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving therapeutic outcomes for patients. Through his work, he continues to influence the field of inhalation therapies significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile